2021
DOI: 10.1007/s40273-021-01044-3
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Objectives For anaemic elective surgery patients, current clinical practice guidelines weakly recommend the routine use of iron, but not erythrocyte-stimulating agents (ESAs), except for short-acting ESAs in major orthopaedic surgery. This recommendation is, however, not based on any cost-effectiveness studies. The aim of this research was to (1) systematically review the literature regarding cost effectiveness of preoperative iron and/or ESAs in anaemic, elective surgery patients and (2) update existing econo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

3
3

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 34 publications
0
3
0
Order By: Relevance
“…These conclusions were confirmed by re-running this model with up-to-date effectiveness data and by using recent cost data of ESAs, iron, and blood products. 24…”
Section: Effectiveness Of Preoperative Iron/esas On Patient-important...mentioning
confidence: 99%
“…These conclusions were confirmed by re-running this model with up-to-date effectiveness data and by using recent cost data of ESAs, iron, and blood products. 24…”
Section: Effectiveness Of Preoperative Iron/esas On Patient-important...mentioning
confidence: 99%
“…Therefore, in a follow-up project, three full-systematic reviews were conducted to gather the best available scientific evidence on the effectiveness (review 1) [ 8 ], safety (review 2), and cost-effectiveness (review 3) [ 9 ] of iron and/or ESA therapy in adult patients with preoperative anemia undergoing elective surgery. The current systematic review (review 2) focused on the occurrence of adverse events (AEs) during or after treatment with iron and/or ESAs.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, in a follow-up project, three full systematic reviews were conducted to gather the best available scientific evidence on the effectiveness (review 1)(8), safety (review 2) and cost-effectiveness (review 3)(9) of iron and/or ESA therapy in adult patients with preoperative anaemia undergoing elective surgery. The current systematic review (review 2) focused on the occurrence of adverse events (AEs) during or after treatment with iron and/or ESAs.…”
Section: Introductionmentioning
confidence: 99%